Does vascular endothelial growth factor in the rheumatoid synovium predict joint destruction? A clinical, radiological, and pathological study in 12 patients monitored for 10 years

Joint Bone Spine

Volumn 68, Issue 6, 2001, Pages 493-498

  Latour, Frédérique ^a   Zabraniecki, Laurent ^a   Dromer, Carole ^a   Brouchet, Anne ^b   Durroux, Régine ^b   Fournié, Bernard ^a  

^a CHU PURPAN   (France)

^b CHU RANGUEIL   (France)

Author keywords

Angiogenesis; Rheumatoid arthritis; VEGF

Indexed keywords

VASCULOTROPIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JOINT DESTRUCTION; MACROPHAGE; MALE; MICROSCOPY; PATIENT MONITORING; PROTEIN ANALYSIS; QUANTITATIVE ASSAY; RADIODIAGNOSIS; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0035678531     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(01)00313-X     Document Type: Article

References (28)

1. The pathophysiology of angiogenesis
2. Vascular endothelial growth factor, a multifunctional polypeptide
3. Molecular and biological properties of the vascular endothelial growth factor family of proteins
4. Standardized radiological valuation of rheumatoid arthritis in therapeutic trials
5. Intracellular pool of vascular endothelial growth factor in human neutrophils
6. Angiogenesis: New aspects relating to its initiation and control
7. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
8. Vascular endothelial growth factor (VEGF) and its receptors
9. Suppression of arthritis and protection from bone destruction by treatment with TNP-470/AGM 1470 in a transgenic mouse model of rheumatoid arthritis
10. Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis
11. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis
12. Vascular endothelial growth factor in patients with rheumatoid arthritis
13. Serum concentrations of vascular endothelial growth factor in collagen diseases
14. Levels of vascular endothelial growth factor in serum and synovial fluid of patients with rheumatoid arthritis
15. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis
16. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis
17. Longitudinal study of rheumatoid arthritis patients discloses sustained elevated serum levels of soluble CD 106 (V-CAM)
18. Serum levels of angiogenic growth factors in patients with early synovitis
19. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
20. A cytokine modulating endothelial function in rheumatoid arthritis
21. Expression of vascular endothelial growth factor by synovial fluid neutrophils in rheumatoid arthritis (RA)
22. Role of vascular endothelial growth factor in angionenesis of rheumatoid arthritis
23. Intratumor microvessel density as a pronostic factor in cancer
24. Localization of vascular endothelial growth factor in synovial membrane mast cells: Examination with 'multilabelling subtraction immunostaining'
25. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis
26. Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arhritis
27. Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells
28. Target molecules for anti-angiogenic therapy: From basic research to clinical trials